Page last updated: 2024-09-03

ulipristal acetate and Endometrial Hyperplasia

ulipristal acetate has been researched along with Endometrial Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H1
Barlow, DH; Bergeron, C; Ferenczy, A; Williams, AR1

Trials

1 trial(s) available for ulipristal acetate and Endometrial Hyperplasia

ArticleYear
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2012, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Biopsy; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Progesterone

2012

Other Studies

1 other study(ies) available for ulipristal acetate and Endometrial Hyperplasia

ArticleYear
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
    Reproductive biology and endocrinology : RB&E, 2018, Apr-03, Volume: 16, Issue:1

    Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence

2018